E Javelle1, D Raoult2. Show Affiliations » 1. Laveran Military Teaching Hospital, Department of Infectious Diseases and Tropical Medicine, French Military Medical Services, France; Aix-Marseille Université, IRD, AP-HM, SSA, VITROME, France; IHU-Méditerranée Infection, IRD, AP-HM, SSA, MEPHI, Marseille, France. Electronic address: emilie.javelle@gmail.com. 2. IHU-Méditerranée Infection, IRD, AP-HM, SSA, MEPHI, Marseille, France; Aix-Marseille Université, IRD, AP-HM, SSA, MEPHI, Marseille, France.
Abstract
Entities: Species
Mesh： See more » Anti-Infective Agents/therapeutic useCarrier State/drug therapyCarrier State/epidemiologyDisease Eradication/methodsDisease Eradication/organization & administrationGlobal HealthHumansMicrobiota/drug effectsPoliomyelitis/drug therapyPoliomyelitis/epidemiologyPoliomyelitis/etiologyPoliovirus/drug effectsPoliovirus/immunologyPoliovirus Vaccine, Inactivated/administration & dosagePoliovirus Vaccine, Inactivated/supply & distributionPoliovirus Vaccine, Oral/adverse effectsVirus Shedding
Substances： See more » Anti-Infective AgentsPoliovirus Vaccine, InactivatedPoliovirus Vaccine, Oral
Year: 2020 PMID： 31935566 DOI： 10.1016/j.cmi.2020.01.005
Source DB: PubMed Journal: Clin Microbiol Infect ISSN： 1198-743X Impact factor: 8.067